To make life-saving cancer treatments more affordable, the National Pharmaceutical Pricing Authority (NPPA) has ordered nationwide strict monitoring of revised prices for 137 non-scheduled anti-cancer drugs.
Operating under the Department of Pharmaceuticals, the regulatory body has directed State Drug Controllers (SDCs) to submit comprehensive Action Taken Reports (ATRs) by November 16, 2026, to verify that price reductions are reaching patients on the ground.
The directive follows the government’s Gazette Order issued on October 17, 2026, which brought these 137 critical medications under the ambit of Trade Margin Rationalisation (TMR)—a policy designed to curb exorbitant markups in the pharmaceutical supply chain. The newly capped Maximum Retail Prices (MRPs) officially came into effect on November 9, 2026.
To ensure complete transparency, the NPPA has compiled the latest revised price lists—incorporating company submissions received up to November 11—and made them accessible via the official NPPA website as well as the Pharma Sahi Daam mobile app and web portal.
Under the new mandate, all stakeholders across the healthcare supply chain—including pharmaceutical manufacturers, stockists, dealers, retail pharmacies, hospitals, and medical institutions—must strictly adhere to the revised pricing. Furthermore, they are legally required to prominently display the updated price lists on their websites and at their physical premises for public verification.
The NPPA has tasked State Drug Controllers with conducting rigorous inspections to prevent profiteering. Any entity found selling these medications above the revised MRP will face strict overcharging proceedings and penalties under the provisions of the Drugs (Prices Control) Order (DPCO), 2013.
Patients and caregivers encountering overcharging, artificial shortages, or non-availability of these 137 anti-cancer drugs are urged to report violations directly to the authorities through the following channels:
-
App/Portal: Pharma Sahi Daam
-
Toll-Free Helpline: 1800-111-255
-
Email: monitoring-nppa@gov.in
